Email ID
Password
Sign me in automatically next time
Public Citizen calls for halt to prasugrel review
04 June 2009
Alex Shimmings

The US FDA's review of Lilly/ Daiichi Sankyo 's novel antiplatelet therapy prasugrel (Effient) should be halted until a new Phase III study looking at a lower, safer dose has been performed, Public Citizen's Health Research Group has urged the new FDA commissioner Dr Margaret Hamburg.
In a...



Please Login to read the full article.
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK Promote your vacancy here
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36